Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Inventory Average (2019 - 2025)

BioNexus Gene Lab's Inventory Average history spans 7 years, with the latest figure at $842075.5 for Q4 2025.

  • Quarterly results put Inventory Average at $842075.5 for Q4 2025, down 39.37% from a year ago — trailing twelve months through Dec 2025 was $842075.5 (down 39.37% YoY), and the annual figure for FY2025 was $1.0 million, down 18.25%.
  • Inventory Average for Q4 2025 was $842075.5 at BioNexus Gene Lab, down from $1.1 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $1.6 million in Q3 2021 to a low of $842075.5 in Q4 2025.
  • The 5-year median for Inventory Average is $1.2 million (2024), against an average of $1.2 million.
  • The sharpest move saw Inventory Average surged 17784.94% in 2021, then tumbled 40.79% in 2023.
  • Year by year, Inventory Average stood at $1.5 million in 2021, then crashed by 31.1% to $1.0 million in 2022, then increased by 8.29% to $1.1 million in 2023, then increased by 23.69% to $1.4 million in 2024, then tumbled by 39.37% to $842075.5 in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $842075.5, $1.1 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.